Use access key #2 to skip to page content.
$71.38 0.10 (0.14%)
7/23/2008 4:00 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View All Commentary (BIIB)

Recs

0

Avatar mes123 (38.13) Submitted: 3/13/08 9:34 AM : Outperform Start Price: $59.08 BIIB Score: 21.82

Unmet needs is definitely a place to make your niche.

Report this Post Replies: 0 | Reply

Featured Broker Partners